When the FDA approved Gilead’s Truvada (emtricitabine/tenofovir disoproxil) for HIV PrEP in 2012, it was a revolutionary step forward. The drug was safe and up to 99 percent effective in preventing HIV infection in at-risk individuals. Then in 20…
How did we Americans allow health insurers to dictate how physicians practice good medicine? The hypocritic oath says, “Do no harm.” We should not allow insurance company profits to prevent proper care for patients. Our insurer is now telli…
I was asked this question at least three times this week, so I think there must be something going around. It doesn’t help that a Kardashian with 140 million Instagram followers recently signed a deal to become an equity partner and global spokeswoman…
In 2017, Allergan CEO Brent Saunders promised to reign in drug price hikes, and other Pharma companies followed suit. In 2021, it looks like all bets are off. In August, Amgen raised the price of its psoriasis med Otezla by 2.4 percent after raising th…
Creative photography Year after year, new medications find their way into the market, adding to the abundant and colorful world of pharmaceuticals. Medications play a dual role in our lives, as they represent wellness and illness concomitantly. I am pr…
Woodworking / Illustration The problem with the act of taking medications is that it’s so mundane that we don’t see any problem with it. This machine-cut, flat, unemotional, same-size-fits-all object that we defencelessly welcome in our very private bo…
Pyrography Medicine bottles are mundane objects tightly woven into our daily lives, with the promise of happier moods, better sleep, and lower blood pressure. Nevertheless, nothing on these objects correlates with hope, faith, or a feeling of healthine…
I just opened my email inbox to see the following headline: “Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) will finally release a draft of their long-awaited federal cannabis…
“The FDA recommended an updated boxed warning and standardization of product labels across the drug class. They recommended judicious prescribing and a gradual taper to mitigate withdrawal reactions. While I am optimistic about these changes, the…
The Food and Drug Administration (FDA) negated the recommendation of its expert panel and approved Aduhelm to treat Alzheimer’s dementia (AD), contending that the possible benefit trumped the lack of evidence of efficacy. The FDA was inexcusably in err…